• Antioxidants for chronic kidney disease 

      Jun, Min; Venkataraman, Vinod; Razavian, Mona; Cooper, Bruce; Zoungas, Sophia; Ninomiya, Toshiharu; Webster, Angela C; Perkovic, Vlado
      Published 2012-10-17
      Background Chronic kidney disease (CKD) is a significant risk factor for premature cardiovascular disease and death. Increased oxidative stress in people with CKD has been implicated as a potential causative factor for ...
      Open Access
      Article
    • Antiplatelet agents for chronic kidney disease 

      Razavian, Mona; Di Micco, Lucia; Palmer, Suetonia C; Craig, Jonathan C; Perkovic, Vlado; Zoungas, Sophia; Webster, Angela C; Jardine, Meg J; Strippoli, Giovanni FM
      Published 2013-02-28
      To evaluate the benefits and harms of antiplatelet therapy in patients with any form of kidney disease, including patients with CKD not receiving renal replacement therapy (RRT), patients receiving any form of dialysis, ...
      Open Access
      Article
    • Research priorities in chronic kidney disease for Australia: Report of a conference 

      Tong, Allison; Crowe, Sally; Chando, Shingisai; Cass, Alan; Chadban, Steve J; Chapman, Jeremy R; Gallagher, Martin; Hawley, Carmel M; Hill, Sophie; Howard, Kirsten; Johnson, David W; Kerr, Peter G; McKenzie, Anne; Parker, David; Perkovic, Vlado; Polkinghorne, Kevan R; Pollock, Carol; Strippoli, Giovanni FM; Tugwell, Peter; Walker, Rowan G; Webster, Angela C; Wong, Germaine; Craig, Jonathan C
      Published 2015-05-03
      Research aims to improve health outcomes for patients. However, the setting of research priorities is usually performed by clinicians, academics, and funders, with little involvement of patients or caregivers and using ...
      Open Access
      Article